LITT
Try LITT free
BANK OF BARODA v NEOPHARMA [2026] DIFC CFI 043 — Renewed permission to appeal dismissed (22 January 2026)
The litigation centers on a claim brought by the Bank of Baroda (DIFC Branch) against Neopharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and the Fourth Defendant (D4), Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEOPHARMA [2025] DIFC CFI 043 — Wasted costs application against legal representatives and expert witnesses (22 August 2025)
The Bank of Baroda (DIFC Branch) initiated this application following a successful judgment against Mr Bavaguthu Raghuram Shetty for USD 33,248,029.70. Seeking to recover legal expenses incurred after an unsuccessful immediate judgment application on 15 January 2024, the Bank targeted the…
BANK OF BARODA v NEOPHARMA [2025] DIFC CFI 043 — Dismissal of permission to appeal against USD 33.2 million judgment (06 May 2025)
The DIFC Court of First Instance rejects an application for permission to appeal a multi-million dollar guarantee judgment, citing procedural non-compliance and a lack of real prospects of success.
BANK OF BARODA v NEOPHARMA [2025] DIFC CFI 043 — Final assessment of costs following USD 33M judgment (14 January 2025)
The litigation concerned the enforcement of financial obligations, culminating in a judgment in favor of the Bank for USD 33,248,029.70. Following the trial, the Court ordered the Fourth Defendant, Mr. Shetty, to pay the Bank’s legal costs, which were subject to immediate assessment.
BANK OF BARODA v NEOPHARMA [2024] DIFC CFI 043 — Final judgment against B.R. Shetty (25 November 2024)
Chief Justice Wayne Martin enters a multi-million dollar judgment against the Fourth Defendant, Bavaguthu Raghuram Shetty, following the conclusion of trial proceedings in the long-running commercial dispute.
BANK OF BARODA v NEOPHARMA [2024] DIFC CFI 043 — Expert handwriting evidence deadlines (08 November 2024)
The DIFC Court of First Instance imposes a strict timeline for the submission of expert handwriting evidence ahead of the scheduled trial in the long-running dispute between Bank of Baroda and the Neopharma/NMC Healthcare group.
BANK OF BARODA v NEOPHARMA [2024] DIFC CFI 043 — Extension of time for expert handwriting evidence (30 October 2024)
The litigation involves complex allegations of financial liability spanning multiple entities, including Neopharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEOPHARMA [2024] DIFC CFI 043 — Variation of expert evidence timelines (01 October 2024)
The litigation involves a substantial claim brought by the DIFC branch of the Bank of Baroda against Neopharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEO PHARMA [2024] DIFC CFI 043 — Consent order regarding procedural timelines for forgery trial (29 August 2024)
The DIFC Court of First Instance formalizes a procedural timeline for the production of witness evidence in the ongoing dispute concerning the alleged forgery of personal guarantees by Mr. Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEO PHARMA [2023] DIFC CFI 043 — Procedural progression of the Immediate Judgment Application (03 November 2023)
The litigation, which has been ongoing since 2020, involves complex claims brought by the Bank of Baroda (DIFC Branch) against Neo Pharma, NMC Healthcare, New Medical Centre, and Mr. Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEO PHARMA [2023] DIFC CFI 043 — Procedural timeline for immediate judgment (02 October 2023)
The litigation involves a high-stakes banking dispute initiated by the Bank of Baroda (DIFC Branch) against a group of entities and individuals, including NEO Pharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Mr. Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEOPHARMA [2023] DIFC CFI 043 — Procedural scheduling for immediate judgment (30 August 2023)
The lawsuit concerns a high-stakes commercial banking dispute brought by the Bank of Baroda (DIFC Branch) against a group of entities and individuals, including Neopharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEOPHARMA [2023] DIFC CFI 043 — Consent order adjourning CMC pending immediate judgment application (13 July 2023)
The lawsuit, filed under CFI 043/2020, involves the Bank of Baroda (DIFC Branch) as the Claimant, pursuing claims against a group of entities and individuals, specifically Neopharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEOPHARMA [2023] DIFC CFI 043 — Procedural directions for trial readiness (08 June 2023)
Justice Sir Peter Gross issues a Further Ruling to safeguard the September 2023 trial date and refine document inspection protocols for the Fourth Defendant.
BANK OF BARODA v NEOPHARMA [2023] DIFC CFI 043 — Document production and forgery allegations (02 June 2023)
The dispute centers on the Claimant’s refusal to produce certain documents requested by the first defendant (Neopharma LLC) and the fourth defendant (Bavaguthu Raghuram Shetty). The defendants sought these materials to substantiate their respective defenses, with the fourth defendant specifically…
BANK OF BARODA v NEOPHARMA [2023] DIFC CFI 043 — Procedural timeline adjustments via consent order (25 April 2023)
The lawsuit concerns a high-stakes banking and finance dispute involving Bank of Baroda (DIFC Branch) and several corporate entities associated with the NMC Healthcare group, alongside Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEOPHARMA [2023] DIFC CFI 043 — Procedural extension for witness evidence (30 March 2023)
The litigation involves a high-stakes dispute between the Bank of Baroda (DIFC Branch) and multiple defendants, including Neopharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEOPHARMA [2023] DIFC CFI 043 — Procedural extension for document production (03 March 2023)
The litigation in CFI 043/2020 involves a high-stakes financial claim brought by the Bank of Baroda (DIFC Branch) against a group of corporate entities and an individual, specifically Neopharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEOPHARMA [2023] DIFC CFI 043 — Procedural extension for document production (16 January 2023)
The litigation under case number CFI 043/2020 involves the Bank of Baroda (DIFC Branch) as the Claimant, pursuing claims against a group of entities and an individual, namely Neopharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEOPHARMA [2022] DIFC CFI 043 — Case Management Order (17 October 2022)
A comprehensive procedural roadmap establishing the trial timeline and disclosure obligations for the complex multi-party commercial dispute between Bank of Baroda and the Neopharma/NMC Healthcare group.
BANK OF BARODA v NEO PHARMA [2022] DIFC CFI 043 — Procedural extension for filing of Reply (17 June 2022)
The litigation involves a complex dispute between Bank of Baroda and several entities, including Neo Pharma LLC and Mr. Bavaguthu Raghuram Shetty. As the case progressed through the Court of First Instance, the parties reached a consensus regarding the timeline for the exchange of pleadings.
BANK OF BARODA v NEO PHARMA [2022] DIFC CFI 043 — Procedural timeline adjustment for complex multi-party litigation (13 May 2022)
The litigation involves a high-stakes claim initiated by Bank of Baroda against a series of corporate entities and an individual, specifically Neo Pharma LLC, NNMC Healthcare LLC, New Medical Centre LLC, and Mr. Bavaguthu Raghuram Shetty.
BANK OF BARODA v NEO PHARMA [2022] DIFC CFI 043 — Consent order for amendment of pleadings (29 March 2022)
The dispute involves Bank of Baroda and a group of corporate and individual respondents, including Neo Pharma LLC, NNMC Healthcare LLC, New Medical Centre LLC, and Mr. Babaguthu Raghuram Shetty.
BANK OF BARODA v NEO PHARMA [2020] DIFC CFI 043 — Consent stay pending ADGM administration (16 December 2020)
The litigation initiated by Bank of Baroda (DIFC Branch) in May 2020 represented a high-stakes recovery effort against multiple defendants, including Neo Pharma LLC, NMC Healthcare LLC, New Medical Centre LLC, and Mr. Bavaguthu Raghuram Shetty.